Company Search:
Advanced Search
Sponsored Links
Akorn, Inc. Company Snapshot
Akorn, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Akorn with three other pharmaceutical manufacturers in North America: Indivior Plc (2016 sales of $1.06 billion ), Biomarin Pharmaceutical Inc ($1.12 billion of which 32% was Vimizim), and Opko Health Incorporation ($1.22 billion of which 83% was Diagnostics).

Sales Analysis. During the year ended December of 2016, sales at Akorn were $1.12 billion. This is an increase of 13.4% versus 2015, when the company's sales were $985.08 million. This was the fifth consecutive year of sales increases at Akorn (and since 2011, sales have increased a total of 716%). Sales of Prescription Pharmaceuticals saw an increase of 14.0% in 2016, from $924.47 million to $1.05 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Akorn, Inc.
  Stock Performance Chart for Akorn, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 22.32
(Figures in U.S. Dollars)
1 Week -1.5%   13 Weeks 2.5%  
4 Weeks 6.7%   52 Weeks 18.4%  
Akorn, Inc. Key Data:
  Ticker: AKRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,116,843,000
(Year Ending Jan 2017).
Employees: 2,388
  Currency: U.S. Dollars Market Cap: 2,776,959,741
  Fiscal Yr Ends: December Shares Outstanding: 124,415,759
  Share Type: Common Closely Held Shares: 28,468,701
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.